Multi-Method Patient-Engagement Approach: A Case Example from a PCORI-Funded Training Project

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Sofolahan-Oladeinde Y, Newhouse RP, Lavallee DC, Huang JC, Mullins CD. Early assessment of the 10-step patient engagement framework for patient-centred outcomes research studies: the first three steps. Family Pract. 2017;34(3):272–7.

    Article  Google Scholar 

  2. 2.

    Available from: http://www.pharmacy.umaryland.edu/centers/summerinstitute. [Accessed].

  3. 3.

    Vandigo J, Oloyede E, Aly A, Laird AL, Cooke CE, Mullins CD. Continuous patient engagement in cardiovascular disease clinical comparative effectiveness research. Expert Rev Pharmacoeconom Outcomes Res. 2016;16(2):193–8.

    Article  Google Scholar 

  4. 4.

    Available from: https://www.pcori.org/engagement/what-we-mean-engagement. [Accessed].

  5. 5.

    Mullins CD, Abdulhalim AM, Lavallee DC. Continuous patient engagement in comparative effectiveness research. JAMA. 2012;307(15):1587–8.

    Article  PubMed  CAS  Google Scholar 

  6. 6.

    Forsythe LP, Szydlowski V, Murad MH, Ip S, Wang Z, Elraiyah TA, Fleurence R, Hickam DH. A systematic review of approaches for engaging patients for research on rare diseases. J Gen Intern Med. 2014;29(3):788–800.

    Article  PubMed Central  Google Scholar 

  7. 7.

    Brett J, Staniszewska S, Mockford C, Herron-Marx S, Hughes J, Tysall C, Suleman R. A systematic review of the impact of patient and public involvement on service users, researchers and communities. Patient. 2014;7(4):387–95.

    Article  PubMed  Google Scholar 

  8. 8.

    Ayme S, Kole A, Groft S. Empowerment of patients: lessons from the rare diseases community. Lancet. 2008;371(9629):2048–51.

    Article  PubMed  Google Scholar 

  9. 9.

    Kirwan JR, de Wit M, Bingham CO, Leong A, Richards P, Tugwell P, Voshaar M, Gossec L. Commentary: patients as partners: building on the experience of outcome measures in rheumatology. Arthritis Rheumatol. 2016;68(6):1334–6.

    Article  PubMed  Google Scholar 

  10. 10.

    Merkel PA, Manion M, Gopal-Srivastava R, Groft S, Jinnah H, Robertson D, Krischer JP. The partnership of patient advocacy groups and clinical investigators in the rare diseases clinical research network. Orphanet J Rare Dis. 2016;11(1):66.

    Article  PubMed  PubMed Central  Google Scholar 

  11. 11.

    Available from: https://www.pcori.org/research-results/2015/pcor-training-program-rare-disease-patient-advocates. [Accessed].

  12. 12.

    Available from: https://www.pcori.org/events/2016/advisory-panel-rare-disease-fall-2016-meeting. [Accessed].

  13. 13.

    Available from: https://rarediseases.org/. Accessed.

  14. 14.

    Forsythe LP, Ellis LE, Edmundson L, Sabharwal R, Rein A, Konopka K, Frank L. Patient and stakeholder engagement in the PCORI pilot projects: description and lessons learned. J Gen Intern Med. 2016;31(1):13–21.

    Article  PubMed  Google Scholar 

  15. 15.

    Molster C, Youngs L, Hammond E, Dawkins H. Key outcomes from stakeholder workshops at a symposium to inform the development of an Australian national plan for rare diseases. Orphanet J Rare Dis. 2012;7(1):50.

    Article  PubMed  PubMed Central  Google Scholar 

  16. 16.

    Coulter A. Patient engagement: what works? J Ambul Care Manag. 2012;35(2):80–9.

    Article  Google Scholar 

  17. 17.

    Forman J, Taruscio D, Llera VA, Barrera LA, Coté TR, Edfjäll C, Gavhed D, Haffner ME, Nishimura Y, Posada M. The need for worldwide policy and action plans for rare diseases. Acta Paediatr. 2012;101(8):805–7.

    Article  PubMed  PubMed Central  Google Scholar 

  18. 18.

    Wästfelt M, Fadeel B, Henter J. A journey of hope: lessons learned from studies on rare diseases and orphan drugs. J Intern Med. 2006;260(1):1–10.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We acknowledge the contributions of the National Organization for Rare Disorders (NORD) for their collaboration throughout the development and delivery of the training program; Dr. Divya Shridharmurthy for her project support. We thank the members of the project’s Patient Advisory Committee: Ron Bartek, Friedreich’s Ataxia Research Alliance; Marc Boutin, National Health Council; Christine Brown, National PKU Alliance; Laurie Burke, The Lora Group; Rachel Gomel, PSC Partners Seeking a Cure; Reta Honey Hiers, R.N.C., Tarlov Cyst Disease Foundation; Jack Kelly, Lymphangiomatosis & Gorham’s Disease Alliance; Jacqueline Kraska, formerly with NORD; C. Daniel Mullins, University of Maryland School of Pharmacy; and Christopher Scalchunes, Immune Deficiency Foundation.

Author information

Affiliations

Authors

Corresponding author

Correspondence to T. Rose Love.

Ethics declarations

Funding

This project was funded by the Patient-Centered Outcomes Research Institute under contract 1036-UMD.

Conflict of Interest

All authors declare that they have no conflict of interest.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Oehrlein, E.M., Love, T.R., Anyanwu, C. et al. Multi-Method Patient-Engagement Approach: A Case Example from a PCORI-Funded Training Project. Patient 12, 277–280 (2019). https://doi.org/10.1007/s40271-018-0341-5

Download citation